Riskpilot← Back to searchSign inGet full accessYNGAB Aktiebolag
ABActiveOrg 5592899685Trädgårdsgatan 7Physiotherapy activities · NACE 8695Est. 20201 employees
Revenue 2025
SEK 1,1M
+9% vs 2024
EBITDA margin
24.5%
+15% vs 2024
Equity ratio
61.5%
Financial strength
Net profit 2025
SEK 186K
+10% vs 2024
| Revenue | SEK 1,1M | +9% |
| EBITDA | SEK 271K | +15% |
| Net profit | SEK 186K | +10% |
| Total assets | SEK 697K | +11% |
| Equity | SEK 429K | -3% |
| Employees | 1 | — |
Legal name
YNGAB Aktiebolag
Org number
5592899685
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
14 december 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva verksamhet inom hälso- och sjukvård, friskvård samt rehabilitering, utbildning och föreläsningar, samt därmed förenlig verksamhet. Bolaget ska även bedriva personlig träning och konsultverksamhet inom idrott, samt därmed förenlig verksamhet.
Address
Trädgårdsgatan 7
Email
daniel.yng@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 711 | 849 | 930 | 1 014 | 1 107 |
| Staff expenses | — | −427 | −536 | −490 | — |
| EBITDA | 298 | 124 | 123 | 235 | 271 |
| Depreciation & amort. | −0 | — | — | — | −0 |
| EBIT | 298 | 124 | 123 | 235 | 271 |
| Net financials | — | 0 | 4 | 4 | 13 |
| Profit before tax | 224 | 99 | 128 | 214 | 233 |
| Tax | −49 | −26 | −27 | −45 | −47 |
| Net profit | 175 | 73 | 101 | 169 | 186 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 376 | 501 | 411 | 627 | 697 |
| Equity | 200 | 273 | 273 | 442 | 429 |
| Long-term debt | 0 | — | — | — | 0 |
| Short-term debt | 101 | 128 | 37 | 60 | 93 |
| Total debt | 101 | 128 | 37 | 60 | 93 |
EBITDA margin
24.5%
This company
15.8%
Market median
+55% vs market
20212025
Equity ratio
61.5%
This company
38.2%
Market median
+61% vs market
20212025
Return on equity
43.4%
This company
18.4%
Market median
+136% vs market
20212025
Net profit margin
16.8%
This company
8.1%
Market median
+107% vs market
20212025
Asset turnover
1.59×
This company
1.12×
Market median
+42% vs market
20212025
Debt / equity
0.62×
This company
0.62×
Market median
+0% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DT Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of YNGAB Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Daniel Tommy Yng | Chief Executive Officer | 0 companies |
| Hans Tommy Yng | Deputy Board Member | 0 companies |